Durvalumab in NSCLC: latest evidence and clinical potential. (Record no. 28962210)

MARC details
000 -LEADER
fixed length control field 00827 a2200217 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518003554.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1758-8340
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1177/1758835918804151
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Muñoz-Unceta, Nerea
245 00 - TITLE STATEMENT
Title Durvalumab in NSCLC: latest evidence and clinical potential.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Therapeutic advances in medical oncology
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 1758835918804151 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Burgueño, Isabel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jiménez, Elizabeth
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Paz-Ares, Luis
773 0# - HOST ITEM ENTRY
Title Therapeutic advances in medical oncology
Related parts vol. 10
-- p. 1758835918804151
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1177/1758835918804151">https://doi.org/10.1177/1758835918804151</a>
Public note Available from publisher's website

No items available.